Transfer learning‑based attenuation correction in 99mTc-TRODAT-1 SPECT for Parkinson's disease using realistic simulation and clinical data.

Abstract

Purpose: Dopamine transporter (DAT) SPECT is an effective tool for early Parkinson's disease (PD) detection and heavily hampered by attenuation. Attenuation correction (AC) is the most important correction among other corrections. Transfer learning (TL) with fine-tuning (FT) a pre-trained model has shown potential in enhancing deep learning (DL)-based AC methods. In this study, we investigate leveraging realistic Monte Carlo (MC) simulation data to create a pre-trained model for TL-based AC (TLAC) to improve AC performance for DAT SPECT.

Methods: A total number of 200 digital brain phantoms with realistic ^99mTc-TRODAT-1 distribution was used to generate realistic noisy SPECT projections using MC SIMIND program and an analytical projector. One hundred real clinical ^99mTc-TRODAT-1 brain SPECT data were also retrospectively analyzed. All projections were reconstructed with and without CT-based attenuation correction (CTAC/NAC). A 3D conditional generative adversarial network (cGAN) was pre-trained using 200 pairs of simulated NAC and CTAC SPECT data. Subsequently, 8, 24, and 80 pairs of clinical NAC and CTAC DAT SPECT data were employed to fine-tune the pre-trained U-Net generator of cGAN (TLAC-MC). Comparisons were made against without FT (DLAC-MC), training on purely limited clinical data (DLAC-CLI), clinical data with data augmentation (DLAC-AUG), mixed MC and clinical data (DLAC-MIX), TL using analytical simulation data (TLAC-ANA), and Chang's AC (ChangAC). All datasets used for DL-based methods were split to 7/8 for training and 1/8 for validation, and a 1-/2-/5-fold cross-validation were applied to test all 100 clinical datasets, depending on the numbers of clinical data used in the training model.

Results: With 8 available clinical datasets, TLAC-MC achieved the best result in Normalized Mean Squared Error (NMSE) and Structural Similarity Index Measure (SSIM) (TLAC-MC; NMSE = 0.0143 ± 0.0082/SSIM = 0.9355 ± 0.0203), followed by DLAC-AUG, DLAC-MIX, TLAC-ANA, DLAC-CLI, DLAC-MC, ChangAC and NAC. Similar trends exist when increasing the number of clinical datasets. For TL-based AC methods, the fewer clinical datasets available for FT, the greater the improvement as compared to DLAC-CLI using the same number of clinical datasets for training. Joint histograms analysis and Bland-Altman plots of SBR results also demonstrate consistent findings.

Conclusion: TLAC is feasible for DAT SPECT with a pre-trained model generated purely based on simulation data. TLAC-MC demonstrates superior performance over other DL-based AC methods, particularly when limited clinical datasets are available. The closer the pre-training data is to the target domain, the better the performance of the TLAC model.